Journal of Cancer Therapy

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org
"Healthcare Resource Utilization and Associated Costs in Patients with Advanced Melanoma Receiving First-Line Ipilimumab"
written by Ahmad Tarhini, Shelby L. Corman, Sumati Rao, Kim Margolin, Xiang Ji, Sonam Mehta, Marc F. Botteman,
published by Journal of Cancer Therapy, Vol.6 No.10, 2015
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA.
2020
[2] Establishing the 6-month resource utilization and cost-of-care for the treatment of first-line metastatic BRAF (+) melanoma with combination BRAF & MEK inhibitors
2020
[3] An economic evaluation of pembrolizumab versus other adjuvant treatment strategies for resected high-risk stage III melanoma in the USA
Clinical drug …, 2020
[4] Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
2019
[5] Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US …
2019
[6] Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands
Anti-Cancer Drugs, 2018
[7] Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated wit h Ipilimumab (INTUITION Study).
The Oncologist, 2017
[8] Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United States
2017
[9] Use of chronolithotherapy for better individual healthcare and welfare
Journal of Systems Science and Systems Engineering, 2017
[10] Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
2017
[11] Cost-Effectiveness of Drug Treatments for Advanced Melanoma: A Systematic Literature Review.
Pharmacoeconomics, 2017
[12] Cost-Effectiveness of Drug Treatments for Advanced Melanoma: A Systematic Literature Review
PharmacoEconomics, 2017
[13] A better HEALTHCARE for a better WELFARE? CHRONOBIOLOGY and LITHOTHERAPY: SUSTAINABLE SYSTEMIC SOLUTIONS
Systemic Solutions for Systemic problems, 2015
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top